Cannabidiol, the major non‐psychoactive component of cannabis, has attracted attention due to its antioxidant and anti‐inflammatory properties and the ability to reduce the accumulation of Aβ and hyperphosphorylation of tau in AD [105, 106]. The gene discussed is MAPT; the disease is Alzheimer disease.